mRNA technology promises vaccines that could be easily produced and highly effective against disease, especially in places with low access to medicines. Here’s how the Bill & Melinda Gates Foundation is ramping up its support.
Read MorePhilanthropy makes up only a small fraction of spending on research and support for people with HIV, still a major threat around the world. In the push for a vaccine, Gates and Gilead are leading the pack.
Read MoreA collaboration of Open Society Foundations, the Clinton Health Access Initiative and other global health organizations and companies aims to augment vaccination efforts with the use of COVID antiviral medicines.
Read MoreEven as COVID recedes in some places, many countries remain overwhelmingly unvaccinated. In its latest big move for vaccine equity, Open Society Foundations committed $100 million to help nations purchase vaccines.
Read MoreA handful of funders heard that researchers in Texas needed money to finish developing a low-cost COVID vaccine. Now, it's poised for mass distribution in India and other under-vaccinated countries worldwide.
Read MoreEven as philanthropic and public health organizations work to boost supplies of COVID vaccines in low-income countries, funders of COVID vaccine equity face an uphill battle.
Read More
Whether you raise money or give it away,
Inside Philanthropy is an essential resource.
